Page results
-
Introduction Fatigue is a common and invisible symptom that is not always obvious to others such as partners, family members, friends or colleagues. As a result others may not understand the…
-
“No one is invulnerable” – stark messages from patients and staff about the realities of coronavirus
The enormous pressure our staff are under was the focus of a powerful BBC News report about the surge in Covid-19 cases broadcast on Wednesday 6 January.
-
Who are we and what do we do? We are a therapies team comprising of Physiotherapists, Occupational Therapists and Speech and Language Therapists. We see people with neurological conditions who…
-
This page has been written by the Department of Neuroradiology at the National Hospital for Neurology and Neurosurgery (NHNN). Our aim is to provide you with information about endovascular treatments…
-
Joint dislocations and subluxations can commonly occur in patients diagnosed with hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD). Such events can be very…
File results
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment